Engineering & Materials Science
Theranostics
100%
Antigens
69%
Membranes
43%
Imaging techniques
39%
Chemical modification
18%
Pharmacokinetics
9%
Positron emission tomography
8%
Toxicity
7%
Molecules
6%
Tissue
5%
Medicine & Life Sciences
Theranostic Nanomedicine
67%
Prostate-Specific Antigen
52%
Membranes
30%
Prostatic Neoplasms
20%
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
12%
United States Food and Drug Administration
6%
Positron-Emission Tomography
5%
Pharmacokinetics
4%
Sensitivity and Specificity
4%
Clinical Trials
4%
Neoplasm Metastasis
3%
Recurrence
3%
Kidney
3%
Therapeutics
2%
Physics & Astronomy
antigens
65%
membranes
37%
cancer
18%
therapy
12%
metastasis
9%
kidneys
8%
toxicity
7%
linkages
7%
inhibitors
7%
payloads
7%
affinity
7%
determinants
6%
positrons
5%
histories
5%
tomography
5%
molecules
3%
Chemical Compounds
Antigen
43%
Positron
30%
Modification
28%
Kd
19%
Pharmacokinetics
19%
Molecule
8%